Graham Capital Management’s Verve Therapeutics VERV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-63,331
| Closed | -$289K | – | 1609 |
|
|
2025
Q1 | $289K | Buy |
63,331
+22,911
| +57% | +$105K | 0.01% | 974 |
|
|
2024
Q4 | $228K | Sell |
40,420
-31,805
| -44% | -$179K | ﹤0.01% | 1008 |
|
|
2024
Q3 | $350K | Sell |
72,225
-70,289
| -49% | -$340K | 0.01% | 707 |
|
|
2024
Q2 | $695K | Buy |
142,514
+113,872
| +398% | +$556K | 0.02% | 462 |
|
|
2024
Q1 | $380K | Buy |
28,642
+16,057
| +128% | +$213K | 0.01% | 676 |
|
|
2023
Q4 | $175K | Buy |
+12,585
| New | +$175K | ﹤0.01% | 834 |
|